| Literature DB >> 35280158 |
Nicole Lepsy1, Madelaine-Rachel Dering1, Jan Fuge2, Tanja Meltendorf2, Marius M Hoeper2, Ivo Heitland1, Jan C Kamp2, Da-Hee Park2, Manuel J Richter3, Henning Gall3, Hossein A Ghofrani3,4, Dietmar Ellermeier5, Hans-Dieter Kulla6, Karen M Olsson1,2, Kai G Kahl1.
Abstract
Introduction: Chronic thromboembolic pulmonary hypertension (CTEPH) is a potentially life-threatening condition associated with high morbidity and mortality. However, advances in medical, surgical and interventional treatment have markedly improved the outcome of patients with CTEPH. Additional factors potentially influencing quality of life (QoL) and outcome in CTEPH are yet to be defined. Child maltreatment is a major risk factor for unfavorable behavioral, mental as well as physical health outcomes and has been associated with decreased QoL. To date, no study assessed the impact of childhood trauma in patients with CTEPH.Entities:
Keywords: CTEPH; CTQ; childhood maltreatment; childhood trauma questionnaire; chronic thromboembolic pulmonary hypertension; pulmonary hypertension; quality of life
Year: 2022 PMID: 35280158 PMCID: PMC8908105 DOI: 10.3389/fpsyt.2022.821468
Source DB: PubMed Journal: Front Psychiatry ISSN: 1664-0640 Impact factor: 4.157
Figure 1Flowchart of participation.
Characteristics of the patients at baseline.
|
| ||||
|---|---|---|---|---|
| Age (years) | 69 (56–76) | 70 (58–77) | 65 (53–76) | 0.066 |
| Female sex (%) | 55 (51%) | 32 (53%) | 23 (50%) | 0.801 |
| BMI (kg/m2) | 26 (24–31) | 27 (24–32) | 26 (24–30) | 0.383 |
|
| ||||
| History of VTE, | 63 (79%) | 39 (87%) | 24 (69%) | 0.05 |
| Time since CTEPH diagnosis (years) | 4 (3–7) | 4 (3–8) | 4 (2–7) | 0.423 |
|
| ||||
| I/II, | 56 (56%) | 30 (52%) | 26 (60%) | 0.491 |
| III, | 42 (33%) | 26 (45%) | 16 (37%) | |
| IV, | 3 (3%) | 2 (3%) | 1 (2%) | |
| 6MWD (m) | 449 (337–533) | 449 (338–510) | 459 (330–545) | 0.462 |
| NT-proBNP (ng/l), | 168 (69–414) | 174 (70–459) | 167 (62–334) | 0.728 |
| DLCO (% pred.) | 62 (53–74) | 63 (51–77) | 62 (55–71) | 0.546 |
| paO2, mmHg | 62 (58–70) | 64 (59–71) | 61 (58–66) | 0.131 |
|
| ||||
| mPAP (mmHg) | 42 (33–50) | 41 (31–48) | 42 (34–52) | 0.470 |
| PAWP (mmHg) | 9 (6–12) | 9 (6–11) | 9 (6–12) | 0.642 |
| CI (l/min/m2) | 2.4 (2–2.8) | 2.2 (2–2.7) | 2.4 (1.9–2.9) | 0.602 |
| PVR (dyn·s·cm−5) | 506 (339–743) | 480 (333–744) | 509 (361–766) | 0.789 |
|
| ||||
| No therapy | 22 (28%) | 8 (18%) | 14 (40%) | 0.07 |
| Monotherapy | 47 (59%) | 29 (64%) | 18 (51%) | |
| Double combination therapy, | 11 (14%) | 8 (18%) | 3 (9%) | |
| OAC, | 101 (94%) | 58 (95%) | 43 (94%) | 0.721 |
|
| ||||
| PEA, | 27 (25%) | 15 (25%) | 12 (26%) | 0.860 |
| BPA, | 37 (35%) | 23 (38%) | 14 (30%) | 0.434 |
| BPA Sessions | 2 (0–5) | 2 (0–5) | 2 (0–5) | 0.869 |
|
| ||||
| Active, | 2 (2%) | 1 (2%) | 1 (2%) | 0.941 |
| Former, | 45 (42%) | 25 (41%) | 20 (44%) | |
| Never, | 60 (56%) | 35 (57%) | 25 (54%) | |
| Packyears | 12 (8–26) | 9 (5–26) | 18 (11–29) | 0.523 |
|
| ||||
| Drinking (drinks per week) | 0 (0–2) | 0 (0–2) | 0 (0–2) | 0.753 |
| Exercise Score (points) | 3 (2–4) | 3 (2–4) | 3 (2–4) | 0.509 |
| HADS-A (points) | 5 (2–9) | 5 (3–9) | 4 (2–7) | 0.190 |
| HADS-D (points) | 5 (2–8) | 6 (4–9) | 4 (1–6) |
|
| QoL-overall (points) | 72 (65–85) | 70 (63–78) | 81 (69–92) |
|
| QoL-psych (points) | 71 (58–79) | 63 (50–79) | 75 (59–86) |
|
| QoL-physical (points) | 64 (53–79) | 61 (50–73) | 71 (59–82) |
|
Continuous variables are stated as median and interquartile ranges (IQR) and categorical variables are stated as n and percent (%), unless indicated otherwise. Mean and SD used because of distribution of the data.
Non-parametric Pearson's chi-squared test used because of nominal scale of the variable.
Non-parametric Mann–Whitney-U-Test used because of ordinal scale of the variable.
There were no cases for triple combination therapy. Statistically significant values are shown as bold.
CM, child maltreatment; BMI, body mass index; QoL, quality of life; HADS-A, hospital anxiety and depression scale—anxiety; HADS-D, hospital anxiety and depression scale—depression; WHO FC, World Health Organization Functional Class; 6MWD, six-minute walking distance; BNP, brain natriuretic peptide; NT-proBNP, N-terminal fragment of pro-brain natriuretic peptide; DLCO, diffusion capacity of the lung for carbon monoxide; paO.
Prevalence of child maltreatment and its subtypes of CTEPH in comparison to data from the general German population.
|
|
|
| |
|---|---|---|---|
| Emotional abuse | 22 (20.6%) | 254 (10.2%) |
|
| Physical abuse | 21 (19.6%) | 301 (12.0%) |
|
| Emotional neglect | 23 (21.5%) | 348 (13.9%) |
|
| Physical neglect | 49 (45.8%) | 1,210 (48.4%) | 0.598 |
| Sexual abuse | 6 (5.6%) | 156 (6.2%) | 0.791 |
Child maltreatment prevalence rates per group stated as percent (%), CTEPH, chronic thromboembolic pulmonary hypertension; n, total number of participants. Statistically significant values are shown as bold.
Partial correlation (Spearman's r) of CTQ-Scores in CTEPH with HADS, QoL, Lifestyle, and WHO FC adjusted for age and gender.
|
|
|
|
|
|
|
|
|
|
| |
|---|---|---|---|---|---|---|---|---|---|---|
| CTQ-TS | 0.240 | 0.369 | −0.324 | −0.383 | −0.250 | 0.130 | −0.211 | −0.002 | 0.060 | 0.157 |
| CTQ-EA | 0.253 | 0.248 | −0.277 | −0.242 | −0.253 | 0.201 | −0.196 | 0.015 | 0.103 | 0.126 |
| CTQ-EN | 0.234 | 0.276 | −0.262 | −0.348 | −0.179 | 0.033 | −0.197 | −0.024 | 0.143 | 0.146 |
| CTQ-PA | 0.206 | 0.266 | −0.233 | −0.241 | −0.265 | 0.155 | −0.117 | 0.043 | −0.072 | 0.008 |
| CTQ-PN | 0.129 | 0.299 | −0.241 | −0.298 | −0.184 | 0.161 | −0.204 | −0.014 | −0.040 | 0.204 |
| CTQ-SA | 0.234 | 0.245 | −0.359 | −0.363 | −0.266 | 0.067 | −0.041 | −0.081 | −0.155 | 0.001 |
CTQ-TS, childhood trauma questionnaire total score; CTQ-EA, childhood trauma questionnaire emotional abuse; CTQ-EN, childhood trauma questionnaire emotional neglect; CTQ-PA, childhood trauma questionnaire physical abuse; CTQ-PN, childhood trauma questionnaire physical neglect; CTQ-SA, childhood trauma questionnaire sexual abuse; HADS-D, hospital anxiety and depression scale—depression; HADS-A, hospital anxiety and depression scale—anxiety; QoL, WHO Quality of Life Questionnaire—total score; Phys. QoL., WHO Quality of Life Questionnaire—physical score; Psych. QoL, WHO Quality of Life Questionnaire—psychological score; BMI, body mass index; WHO FC, World Health Organization Functional Class.
p < 0.01.
p < 0.05.